Home / Generics

Generics

News

Teva wins another Symbicort patent challenge posted 12/09/2014

Teva Pharmaceutical Industries (Teva) has gained another win in its campaign to launch a generic version of AstraZeneca’s ast...

FDA accepts applications for three-times-weekly follow-on Copaxone posted 08/09/2014

The US Food and Drug Administration (FDA) has accepted applications submitted by generics makers Dr Reddy’s, Sandoz (Momenta...

Generics companies sue Reckitt Benckisser over generics supplies posted 08/09/2014

Three generics companies are suing Reckitt Benckisser (Reckitt) for failing to provide generics supplies of its cold and flu...

US court puts generic Gralise on hold posted 03/09/2014

US specialty drugmaker Depomed has received a favourable preliminary verdict in its case against generics manufacturer Actavi...

Generics manufacturers focus on MS drug Ampyra posted 22/08/2014

Following news that Acorda Therapeutics (Acorda) was preparing to defend its intellectual property rights against a competito...

 

Research

Pharma’s future in China and the US posted 12/09/2014

Although generics will increase their share of all prescriptions in China and the US over the next 10 years, economic and str...

Appropriate generics pricing improves medicines availability in Sri Lanka posted 05/09/2014

The wide availability of generics across Sri Lanka, in both private and semi-government community pharmacies, is increasing t...

Value of generics overlooked in one country that needs them most: Greece posted 29/08/2014

A study of physicians’ prescribing patterns and perceptions towards generics in Greece has revealed a clear need for an appro...

Trends in the financial burden of diabetes treatment posted 22/08/2014

The number of adults diagnosed with diabetes in the US increased 75% between 2000 and 2010, resulting in 9% of the adult popu...

Right of appeal provision in CETA posted 14/08/2014

The Comprehensive Economic and Trade Agreement (CETA) between the European Union (EU) and Canada has the potential to have a...

 

General

Generic hepatitis drug to be made available to 80 countries posted 15/09/2014

Originator pharma company Gilead Sciences (Gilead) is reportedly close to reaching a deal with generics makers to bring low c...

Lawyers look at new price hike for old drug posted 29/08/2014

Two generic drug companies are being investigated by the Connecticut Attorney General’s office following reports of alarming...

Ranbaxy’s manufacturing woes benefit big pharma posted 25/08/2014

Import bans by the US Food and Drug Administration (FDA) on generics from four of Ranbaxy Laboratories’ (Ranbaxy) manufacturi...

Recalls call into question metoprolol generics posted 08/08/2014

Recent recalls have vindicated a cardiologist’s warnings about generic versions of a widely used heart drug, Toprol XL (metop...

India planning to extend pricing control to more drugs posted 01/08/2014

India is thought likely to increase the number of drugs it considers ‘essential’ and therefore for which it controls the maxi...

Generics News Research General

more

Biosimilars News Research General

more